Betmiga (mirabegron)
Overactive Bladder
ApprovedCommercial
Key Facts
About Astellas Pharma
Astellas Pharma Inc. is one of Japan's leading pharmaceutical companies with a global presence, dedicated to turning innovative science into value for patients. The company has built a strong portfolio of prescription medicines and is advancing multiple programs through clinical development, with particular expertise in urology, oncology, immunology, and neuroscience. Astellas is committed to becoming a global biopharmaceutical company by leveraging external innovation and strategic partnerships.
View full company profileTherapeutic Areas
Other Overactive Bladder Drugs
| Drug | Company | Phase |
|---|---|---|
| Vesicare (solifenacin) | Astellas Pharma | Approved |
| Vibegron | Sumitomo Pharma | Approved/Commercial |